Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor  被引量:43

Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor

在线阅读下载全文

作  者:付小兵[1] 郭振荣[1] 盛志勇[1] 沈祖尧[2] 张明良[2] 

机构地区:[1]解放军304医院,北京100037 [2]积水潭医院烧伤科,北京100035

出  处:《Chinese Medical Journal》2002年第3期331-335,共5页中华医学杂志(英文版)

基  金:supported partially by the National Grant for Outstanding Young Researchers (No.39525024); the Major State Basic Development Program (No.G1999054204).

摘  要:OBJECTIVE: To evaluate the safety and efficacy of topical application of recombinant bovine basic fibroblast growth factor (rbFGF) on the healing of chronic cutaneous wounds. METHODS: Twenty-eight patients with thirty-three chronic cutaneous wounds resulting from trauma, diabetes mellitus, pressure sore and radiation injuries were enrolled in this prospective, open-label crossover trial. Prior to treatment with rbFGF, all wounds failed to heal with conventional therapies within 4 weeks. All wounds were locally treated with rbFGF at a dose of 150 AU/cm(2). Healing time and the quality of wounds were used to evaluate the efficacy of the treatment. RESULTS: Healing of all chronic wounds was expedited. During the study, eighteen wounds completely healed within 2 weeks, four healed within 3 weeks, and another eight completely healed within 4 weeks. Only three wounds failed to heal within 4 weeks, but healed at 30, 40 and 42 days after treatment with rbFGF. Thus, compared with conventional therapies, the effective rate of rbFGF treatment within 4 weeks was 90.9%. Histological assessment showed more abundant capillary sprouts or tubes and that fibroblasts were differentiated in wounds treated with rbFGF. No adverse side effects related to basic fibroblast growth factor were observed. CONCLUSIONS: Our results indicate that rbFGF could be used to accelerate healing in chronic wounds. It is our belief that this may be a more effective method of chronic wound management.目的 观察重组中碱性成纤维细胞生长因子 (rbFGF)对慢性难愈合创面 (溃疡 )的促修复作用并探讨其促修复机制。方法 本组 2 8例共 33个慢性难愈合创面 ,其中创伤性溃疡 12例 (13个创面 )、压迫性溃疡 9例 (13个创面 ) ,糖尿病溃疡 4例 ,放射性溃疡 3例。所有创面经清创后用rbFGF治疗 (15 0AU/cm2 创面 ,每天 1次 )。结果 所有经rbFGF治疗的创面都产生了明显的愈合 ,其中 2周内愈合为 18例 ,2 - 3周内愈合为 4例 ,3- 4周内愈合为 8例 ,大于 4周愈合的创面为 3例。本组创面 4周内总愈合率为 90 9%。结论 rbFGF可以明显加速慢性难愈合创面愈合 ,其可能的机制涉及外源性bFGF能够补充内源性bFGF的不足或调控内源性bFGF活性。

关 键 词:Wound Healing Administration  Topical Adolescent Adult Aged Aged  80 and over Child Chronic Disease Female Fibroblast Growth Factor 2 Humans Male Middle Aged Recombinant Proteins Research Support  Non-U.S. Gov't Skin Skin Ulcer 

分 类 号:R605[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象